Spring 2021 Agenda

Friday, April 16, 2021

7:00 AM - 8:15 AM PME or CME Symposium

SESSION I: OBESITY AND LIFESTYLE MEDICINE

8:20 AM - 8:25 AM Chair Introduction and Opening Remarks
Robert H. Eckel, MD
8:25 AM - 8:45 AM The Evolving Landscape of Obesity Management - A 2021 Update
8:45 AM - 9:05 AM Practical Tips to Help Your Patients Succeed In Their Weight Loss Journey
9:05 AM - 9:25 AM Challenges Cases & Panel Discussions - Practical Approaches to Weight Reduction
Chair: Robert H. Eckel, MD
Panel:
9:25 AM - 9:55 AM Keynote
9:55 AM - 10:25 AM Exhibit Hall Break
10:25 AM - 10:55 AM Expert Perspectives - Best approaches to Diets for Cardiometabolic Health
10:55 AM - 11:25 AM Challenging Cases & Expert Panel Discussion
Chair: Robert H. Eckel, MD
Panel:
11:25 AM - 11:30 AM Closing Remarks
Robert H. Eckel, MD
11:30 AM - 11:45 AM Refresh and Recharge Break
11:45 AM - 12:45 PM PME or CME Symposium
12:45 PM - 1:00 PM Refresh and Recharge Break

SESSION II: DIABETES MANAGEMENT

1:00 PM - 1:05 PM Chair Introduction
Anne L. Peters, MD
1:05 PM - 1:30 PM Glycemic Management in Patients with CVD
1:30 PM - 1:55 PM Exercise as "Medicine" in the Treatment of T2DM
1:55 PM - 2:20 PM Relationship Between TIR and Diabetes Complications
2:20 PM - 2:50 PM What is the Role of CGM in Prediabetes/Type 2 Diabetes?
2:50 PM - 3:20 PM Exhibit Hall Break
3:20 PM - 3:40 PM Inpatient Use of CGM
3:40 PM - 4:10 PM Use of Insulin Pumps in the Management of T2DM
4:10 PM - 4:45 PM Challenges Cases & Panel Discussions
Chair: Anne L. Peters, MD
Panel: Robert H. Eckel, MD
4:45 PM Closing Remarks
Anne L. Peters, MD
4:45 PM - 5:00 PM Refresh and Recharge Break
5:00 PM - 6:00 PM PME or CME Symposium

Saturday, April 17, 2021

7:00 AM - 8:15 AM PME or CME Symposium
8:15 AM - 8:20 AM Take 5 Break

SESSION III: KIDNEY DISEASE / HEART FAILURE / HYPERTENSION

8:20 AM - 8:25 AM Chair Introduction
George L. Bakris, MD
8:25 AM - 10:00 AM CME Supersymposium
New Frontiers in Heart Failure
  1. The Metabolic Face of HF
  2. Biomarkers for risk assessment and prevention of HF
  3. Assessing the new data for HF prevention and treatment
  4. Predicting the impact of these advances: Updates in HF guidelines
  5. HF Challenging Cases & Expert Panel Discussion
10:10 AM - 10:40 AM Exhibit Hall Break
10:40 AM - 11:00 AM Evaluating Risk of CKD Progression
11:00 AM - 11:20 AM Updates in the Prevention and Treatment of CKD
11:20 AM - 11:40 AM Primary Aldosteronism: An Underappreciated Issue in HTN
11:40 AM - 12:00 PM DKD/HTN Challenging Cases & Expert Panel Discussion
Chair: George L. Bakris, MD
Panel:
12:00 PM - 1:00 PM PME or CME Symposium
1:00 PM - 1:05 PM Take 5 Break

SESSION IV: DYSLIPIDEMIA / ATHEROSCLEROSIS / THROMBOSIS

1:05 PM Chair Introduction
Christie M. Ballantyne, MD
1:05 PM - 1:35 PM Risk Prediction: Role of Imaging, Biomarkers, and Genetics
1:35 PM - 1:55 PM Update on Inflammation and CVD
1:55 PM - 2:25 PM Post-MI: When to Start Lipid-lowering Therapy and How Low to Go
2:25 PM - 2:55 PM Exhibit Hall Break
2:55 PM - 3:25 PM Stroke Prevention in the Cardiometabolic Patient with Atrial Fibrillation
3:25 PM - 4:05 PM Antithrombotic and Antiplatelet Therapy in the Cardiometabolic Patient
4:05 PM - 4:25 PM Expert Panel Discussion and Q&A
Chair: Christie M. Ballantyne, MD
Panel: Robert H. Eckel, MD
4:25 PM - 4:30 PM Closing Remarks
Christie M. Ballantyne, MD
4:30 PM - 4:45 PM Refresh and Recharge Break
4:45 PM - 5:45 PM PME or CME Symposium

Sunday, April 18, 2021

Cardiometabolic Risk and COVID-19: Implications and Practice Considerations

7:25 AM - 7:30 AM Introduction and Opening Remarks
7:30 AM - 8:50 AM Impacts of COVID-19 on Cardiometabolic Risk
  1. COVID-19 & Obesity
  2. COVID-19 & Hypertension
  3. COVID-19 and CVD
  4. COVID-19 and T2DM
8:50 AM - 9:20 AM Challenging Cases & Expert Panel Discussion: COVID-19 and Cardiometabolic Diseases
9:20 AM - 10:40 AM Telemedicine in Cardiometabolic Health: The Good, The Bad, and The Ugly
  1. Brief overview of telemedicine
  2. The clinical efficacy of telemedicine for cardiometabolic health
  3. What should you expect from medicine and what you should not
  4. Optimizing reimbursement in telemedicine
10:40 AM - 11:10 AM Interactive Panel Discussion: Optimizing Telemedicine to Meet Immediate and Long-term Demands in the COVID-19 Era
11:10 AM - 11:15 AM Closing Remarks